Pyoderma gangrenosum with pathergy in a pregnant patient without associated systemic disease

Cutis

Volumn 81, Issue 3, 2008, Pages 255-258

  Reddy, Kavitha ^a   Brightman, Lori ^a   Venna, Suraj ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; TRIAMCINOLONE;

ADULT; ARTICLE; BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PYODERMA GANGRENOSUM;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PYODERMA GANGRENOSUM; TRIAMCINOLONE;

EID: 42149083892     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137: 1000-1005.
2. Cairns BA, Herbst CA, Sartor BR, et al. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg. 1994;129:769-772.
3. Freedman AM, Phelps RG, Lebwohl M. Pyoderma gangrenosum associated with anticardiolipin antibodies in a pregnant patient. Int J Dermatol. 1997;36: 205-207.
4. Roger D, Aldigier JC, Peyronnet P, et al. Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus. Clin Exp Dermatol. 1993;18: 268-270.
5. Stone N, Harland C, Ross L, et al. Pyoderma gangrenosum complicating caesarian section. Clin Exp Dermatol. 1995;20:490-491.
6. Steadman UA, Brennan TE, Daman LA, et al. Pyoderma gangrenosum following cesarean delivery. Obstet Gynecol. 1998;19(5, pt 2): 834-836.
7. Sassolas B, Le Ru Y, Plantin P, et al. Pyoderma gangrenosum with pathergic phenomenon in pregnancy. Br J Dermatol. 2000;142:827-828.
8. Keohane S, Graham-Brown R. Pyoderma gangrenosum complicating hysterectomy for fibroids Clin Exp Dermatol. 1995;20:490-491.
9. Futami H, Kodaira M, Furuta T, et al. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone therapy and cyclosporine. J Gastroenterol. 1998;33:408-418.
10. Aytekin S, Tarlan N, Kalkanli N, et al. Pyoderma gangrenosum in pregnancy. J Eur Acad Dermatol Venereol. 2002;16:546-548.
11. Sergent F, Joly P, Gravier A, et al. Pregnancy: a possible etiology of pyoderma gangrenosum. a case report and review of the literature [in French]. J Gynecol Obstet Biol Reprod (Paris). 2002;31:506-511.
12. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55:173-186.
13. Ah-Weng A, Langtry J, Velangi S, et al. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. 2005;30:669-671.
14. Barth J, Layton A, Cunliffe W. Endocrine factors in preand postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134:1057-1059.
15. Attanoos R, Appleton M, Douglas-Jones A. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133:254-258.
16. Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol. 2002;11:487-502.
17. Nerella P, Daniela A, Guido M, et al. Leukocyte chemotaxis and pyoderma gangrenosum. Int J Dermatol. 1985;24:45-47.
18. Blitz N, Rudikoff D. Pyoderma gangrenosum. Mt Sinai J Med. 2001;68:287-297.
19. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156:51-56.
20. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88:289P-290P.